Clinical Trials Logo

Filter by:
NCT ID: NCT05090904 Completed - Cystic Fibrosis Clinical Trials

A Study to Assess the Safety, Tolerability, and Pharmacokinetics of Brensocatib Tablets in Adults With Cystic Fibrosis

Start date: November 30, 2021
Phase: Phase 2
Study type: Interventional

The main objective of the study is to evaluate the pharmacokinetics of brensocatib in participants with cystic fibrosis following once daily oral administration of study drug and to evaluate the safety of brensocatib compared to placebo in participants with cystic fibrosis (CF) over the 4-week treatment period.

NCT ID: NCT05090852 Completed - Clinical trials for Upper Airway Surgery

High Velocity Nasal Insufflation (Hi-VNI) Use in Upper Airway Surgery

Start date: October 22, 2020
Phase: N/A
Study type: Interventional

The goals of this study are to establish the efficacy of Hi-VNI (High Velocity Nasal Insufflation) in upper airway surgery from the anesthesiologist's and surgeon's perspectives, and to describe the ideal patient and the ideal pathology as well as suitable clinical scenarios when this oxygenation technique should be selected.

NCT ID: NCT05090839 Completed - Clinical trials for Post Traumatic Stress Disorder

Expressing Personal Recollections in English or Spanish to Alleviate Traumatic Emotions (Exprésate)

Exprésate
Start date: August 18, 2021
Phase: N/A
Study type: Interventional

The purpose of this study is to test if expressive writing about traumatic events has positive changes in women living with post-traumatic stress.

NCT ID: NCT05090774 Completed - Clinical trials for Peripheral Arterial Disease

Integrating Fall Prevention Balance Exercises Into a Program for Older Adults With Peripheral Artery Disease (PAD): A Mixed Methods Feasibility Study

Start date: October 7, 2021
Phase: N/A
Study type: Interventional

The overarching objective of this study is to improve fall prevention efforts in community-dwelling older adults with peripheral artery disease (PAD) to reduce falls. To accomplish this, the investigators will conduct a feasibility study and pilot the addition of a balance exercise component to existing supervised exercise therapy (SET) programs for PAD. This intervention may be an effective way to help older adults with PAD self-manage their leg pain and walking impairments as well as fall risk. The long-term goal of this research is to reduce morbidity and mortality associated with falls in older adults with symptomatic PAD through the development and evaluation of a balance intervention component implemented within existing exercise programs. Findings from this research may also be translated to the implementation of disease management programs for other chronic conditions associated with fall risk. The rationale for this research is to determine improve disease-specific, comprehensive and fall prevention strategies for older adults with PAD.

NCT ID: NCT05090748 Completed - Cardiac Disease Clinical Trials

Study for the Assessment of the Quality of Echocardiographic Clips.

Start date: May 15, 2022
Phase:
Study type: Observational

This study main objective is to evaluate the safety and efficacy of the UltraSight AI Guidance software. The investigational product is a software that guides the user to capture a high quality ultrasound image. The study will include healthcare professionals, not specialized in echocardiography, who will perform echocardiography by using UltraSight AI Guidance software, on subjects in the medical centers cardiac units.

NCT ID: NCT05090657 Completed - Clinical trials for Nosocomial Infection

Nasal Photodisinfection in All Patients Presenting for Surgery for a Wide Range of Surgical Procedures

BENEFIT-PDT
Start date: February 4, 2022
Phase: Phase 2
Study type: Interventional

This is a Phase 2 single-center, open-label, single-arm, study of a microbiological endpoint using antimicrobial photodynamic therapy (aPDT) for nasal disinfection in all patients (universal) presenting for surgery at an acute care hospital for a wide range of surgical procedures.

NCT ID: NCT05090293 Completed - Clinical trials for Overweight and Obesity

Optimizing Weight Loss Outcomes Through Body Image Enhancement

Start date: September 13, 2021
Phase: N/A
Study type: Interventional

The study will examine if a standard group-delivered cognitive behavioral lifestyle intervention for weight loss can be improved via the incorporation of a novel body image intervention designed to address body image and improve weight loss outcomes in a sample of women with overweight/obesity.

NCT ID: NCT05090280 Completed - Pharmacokinetics Clinical Trials

Pharmacokinetics of Oxycodone and PF614 Co-Administered With Nafamostat

MPAR-101
Start date: December 1, 2021
Phase: Phase 1
Study type: Interventional

A single dose study to assess the pharmacokinetics (PK) of oxycodone, when PF614 is solution is administered alone and with nafamostat as an immediate-release (IR) solution and/or extended-release (ER) capsule prototypes.

NCT ID: NCT05089929 Completed - GERD Clinical Trials

Endoscopic Esophageal Topography (Endoflip 2.0) Versus High-resolution Manometry (HRM)

Start date: March 19, 2020
Phase:
Study type: Observational

The purpose of the study is to investigate the use of FLIP topography in patients undergoing evaluation for gastroesophageal reflux disease (GERD). This device allows the clinician to measure muscle activity in the esophagus during a routine upper endoscopy. The FLIP topography will be used to help detect movement disorders in the esophagus, and to examine differences in patient satisfaction between FLIP topography and the standard of care procedure, high resolution manometry (HRM).

NCT ID: NCT05089903 Completed - Breast Cancer Clinical Trials

Breast Cancer Outreach Among Primary Care Patients

Start date: October 25, 2021
Phase: N/A
Study type: Interventional

This project aims to evaluate different approaches to increase breast cancer screening among primary care patients at Penn Medicine through a centralized screening outreach program. In a pragmatic trial, the investigators will evaluate different approaches to increase completion of screening among eligible patients, including ordering mammograms in bulk prior to outreach, sending personalized text reminders, and endorsing of the communication by the primary care provider.